Review
doi: 10.1007/BF01962550.
New developments in the pharmacotherapy of inflammatory bowel disease
Affiliations
- PMID: 1437510
- DOI: 10.1007/BF01962550
Item in Clipboard
Review
New developments in the pharmacotherapy of inflammatory bowel disease
Pharm Weekbl Sci.
.
Abstract
In this article the clinical features and aetiology of inflammatory bowel diseases are described and current pharmacotherapeutic possibilities are explored. Also reviewed are recent developments and future prospects for the pharmacotherapy of inflammatory bowel diseases, including aminosalicylates, corticosteroids, immunosuppressants, lipoxygenase inhibitors, fish oil, sucralfate, bismuth compounds, free radical scavengers, (hydroxy)chloroquine, sodium cromoglycate and methotrexate.
Similar articles
-
Advances in drug therapy for inflammatory bowel disease.Ann Intern Med. 1990 Jan 1;112(1):50-60. doi: 10.7326/0003-4819-112-1-50. Ann Intern Med. 1990. PMID: 2152845 Review.
-
Pharmacotherapy of inflammatory bowel disease.Dig Dis. 1993 Nov-Dec;11(6):334-42. doi: 10.1159/000171425. Dig Dis. 1993. PMID: 8306490 Review.
-
[Pharmacologic therapy for inflammatory bowel diseases: hopes, disappointments].Internist (Berl). 2005 May;46(5):586-91. doi: 10.1007/s00108-005-1386-9. Internist (Berl). 2005. PMID: 15806413 Review. German.
-
Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.Aliment Pharmacol Ther. 1993 Aug;7(4):369-83. doi: 10.1111/j.1365-2036.1993.tb00110.x. Aliment Pharmacol Ther. 1993. PMID: 8105984 Review.
-
Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy.Prostaglandins Leukot Essent Fatty Acids. 1990 Dec;41(4):215-33. doi: 10.1016/0952-3278(90)90135-8. Prostaglandins Leukot Essent Fatty Acids. 1990. PMID: 2077536 Review. No abstract available.
Cited by
-
Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease.Drugs. 1999 Mar;57(3):383-408. doi: 10.2165/00003495-199957030-00013. Drugs. 1999. PMID: 10193690 Review.
-
Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.Drugs. 2000 Apr;59(4):929-56. doi: 10.2165/00003495-200059040-00016. Drugs. 2000. PMID: 10804042 Review.
-
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.PLoS One. 2016 Nov 15;11(11):e0166455. doi: 10.1371/journal.pone.0166455. eCollection 2016. PLoS One. 2016. PMID: 27846307 Free PMC article.